ADARx Pharmaceuticals, Inc. (ADRX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-07-08 and 2026-10-06, public records show 14 signals for ADARx Pharmaceuticals, Inc.. Most notable: 2026-09-28: 5 insiders bought $87.7M within 14 days; 2026-09-28: GORDON CARL L (director) bought $10.0M of stock; 2026-09-28: ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC (director) bought $10.0M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-06 from public records.
Signals, last 12 months
- Insider buying cluster5 insiders bought $87.7M within 14 days
- Insider purchaseGeorge Simeon (director) bought $10.1M of stock
- Insider purchaseGeorge Simeon (director) bought $10.1M of stock
- Insider purchaseSR ONE CAPITAL MANAGEMENT, LLC (ten_percent_owner) bought $10.1M of stock
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC (director) bought $10.0M of stock
- Insider purchaseSR ONE CAPITAL MANAGEMENT, LLC (ten_percent_owner) bought $10.1M of stock
- Insider purchaseGORDON CARL L (director) bought $10.0M of stock
- Insider purchaseSR ONE CAPITAL MANAGEMENT, LLC (ten_percent_owner) bought $7.1M of stock
- Insider purchaseGeorge Simeon (director) bought $7.1M of stock
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC (director) bought $5.1M of stock
- Insider purchaseGORDON CARL L (director) bought $5.1M of stock
- Insider purchaseChimovits Erez (director) bought $1.0M of stock
- Insider purchaseORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC (director) bought $1.0M of stock
- Insider purchaseGORDON CARL L (director) bought $1.0M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-28 | LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. | ten percent owner | C | 307,738 | — | — |
| 2026-09-28 | LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. | ten percent owner | C | 307,738 | — | — |
| 2026-09-28 | LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. | ten percent owner | C | 153,868 | — | — |
| 2026-09-28 | LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. | ten percent owner | C | 513,067 | — | — |
| 2026-09-28 | LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. | ten percent owner | C | 1,667,469 | — | — |
| 2026-09-28 | LAV Biosciences Fund V, L.P.; LAV Fund VI Opportunities, L.P.; LAV Fund VI, L.P. | ten percent owner | C | 8,908,775 | — | — |
| 2026-09-28 | George Simeon | director | P | 592,593 | 17 | $10,074,081 |
| 2026-09-28 | George Simeon | director | C | 169,001 | — | — |
| 2026-09-28 | George Simeon | director | C | 1,667,468 | — | — |
| 2026-09-28 | George Simeon | director | P | 414,814 | 17 | $7,051,838 |
| 2026-09-28 | George Simeon | director | C | 1,538,691 | — | — |
| 2026-09-28 | George Simeon | director | P | 592,593 | 17 | $10,074,081 |
| 2026-09-28 | George Simeon | director | C | 512,897 | — | — |
| 2026-09-28 | George Simeon | director | C | 1,113,666 | — | — |
| 2026-09-28 | George Simeon | director | C | 3,334,938 | — | — |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | P | 592,593 | 17 | $10,074,081 |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | C | 169,001 | — | — |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | C | 1,667,468 | — | — |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | P | 414,814 | 17 | $7,051,838 |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | C | 1,538,691 | — | — |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | P | 592,593 | 17 | $10,074,081 |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | C | 512,897 | — | — |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | C | 1,113,666 | — | — |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | ten percent owner | C | 3,334,938 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | P | 588,235 | 17 | $9,999,995 |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | P | 61,516 | 17 | $1,045,772 |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 256,448 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 513,067 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 1,333,975 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 7,127,019 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | P | 300,249 | 17 | $5,104,233 |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 564,187 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 769,601 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 2,000,962 | — | — |
| 2026-09-28 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC | director | C | 10,690,530 | — | — |
| 2026-09-28 | GORDON CARL L | director | P | 588,235 | 17 | $9,999,995 |
| 2026-09-28 | GORDON CARL L | director | P | 61,516 | 17 | $1,045,772 |
| 2026-09-28 | GORDON CARL L | director | C | 256,448 | — | — |
| 2026-09-28 | GORDON CARL L | director | C | 513,067 | — | — |
| 2026-09-28 | Chimovits Erez | director | C | 7,127,019 | — | — |
| 2026-09-28 | Chimovits Erez | director | C | 1,333,975 | — | — |
| 2026-09-28 | Chimovits Erez | director | C | 513,067 | — | — |
| 2026-09-28 | Chimovits Erez | director | C | 256,448 | — | — |
| 2026-09-28 | Chimovits Erez | director | P | 61,516 | 17 | $1,045,772 |
| 2026-09-28 | GORDON CARL L | director | C | 10,690,530 | — | — |
| 2026-09-28 | GORDON CARL L | director | C | 2,000,962 | — | — |
| 2026-09-28 | GORDON CARL L | director | C | 769,601 | — | — |
| 2026-09-28 | GORDON CARL L | director | C | 564,187 | — | — |
| 2026-09-28 | GORDON CARL L | director | P | 300,249 | 17 | $5,104,233 |
| 2026-09-28 | GORDON CARL L | director | C | 7,127,019 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.